Market Estimates
Valuation Metrics
Financials
Trading Trends
AGIO News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Agios Pharmaceuticals Inc (AGIO) stock price today?
The current price of AGIO is 28.41 USD — it has increased 0.89 % in the last trading day.
What is Agios Pharmaceuticals Inc (AGIO)'s business?
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its portfolio, PYRUKYND (mitapivat), is an activator of both wild-type and mutant pyruvate kinase, or PK, enzymes for the potential treatment of hemolytic anemias. It is also developing tebapivat, a novel PK activator, for the potential treatment of lower-risk myelodysplastic syndromes, or LR MDS, and hemolytic anemias; AG-181, its phenylalanine hydroxylase, or PAH, stabilizer for the potential treatment of phenylketonuria, or PKU; and AG-236, an siRNA in-licensed from Alnylam Pharmaceuticals, Inc., targeting the transmembrane serine protease 6, or TMPRSS6 gene for the potential treatment of polycythemia vera, or PV.
What is the price predicton of AGIO Stock?
Wall Street analysts forecast AGIO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AGIO is 31.17 USD with a low forecast of 20.00 USD and a high forecast of 48.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Agios Pharmaceuticals Inc (AGIO)'s revenue for the last quarter?
Agios Pharmaceuticals Inc revenue for the last quarter amounts to 12.88M USD, increased 43.69 % YoY.
What is Agios Pharmaceuticals Inc (AGIO)'s earnings per share (EPS) for the last quarter?
Agios Pharmaceuticals Inc. EPS for the last quarter amounts to -1.78 USD, decreased -110.97 % YoY.
What changes have occurred in the market's expectations for Agios Pharmaceuticals Inc (AGIO)'s fundamentals?
How many employees does Agios Pharmaceuticals Inc (AGIO). have?
Agios Pharmaceuticals Inc (AGIO) has 486 emplpoyees as of January 10 2026.
What is Agios Pharmaceuticals Inc (AGIO) market cap?
Today AGIO has the market capitalization of 1.66B USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251227100413_e776fcd83da95a9212eed9a8ac11e255.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251227030257_5119010cde25b129e2fa65be2cb0e69d.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20251226230400_1400d75984527127335a5a50314255e3.jpg&w=384&q=75)